Buck Isaac D
J Leg Med. 2019 Apr-Jun;39(2):121-136. doi: 10.1080/01947648.2019.1645539.
Empowered to play a larger role in the delivery and administration of health care, a number of states are attempting to solve the pharmaceutical pricing crisis in creative and varied ways. This essay summarizes three particular states' more activist approaches, including states that have sought to empower their Medicaid programs to limit coverage of certain drugs based on price, attempted to use leverage to impose cost-efficiency requirements, and, in the most dramatic example, relied on new usage of "gouging" laws to bring down the costs of prescription drugs. Although all three approaches have met substantial resistance, they illustrate a new era of state experimentation in an effort to bring down the cost of prescription drugs.
在医疗保健的提供和管理方面被赋予更大作用后,一些州正试图以创新和多样的方式解决药品定价危机。本文总结了三个特定州更为激进的方法,包括那些寻求授权其医疗补助计划根据价格限制某些药物的覆盖范围、试图利用影响力施加成本效益要求的州,以及在最引人注目的例子中,依靠“哄抬物价”法律的新用途来降低处方药成本的州。尽管这三种方法都遇到了很大阻力,但它们说明了州政府为降低处方药成本而进行试验的新时代。